Acute bacterial meningitis is a rapidly progressive, life-threatening infection of the leptomeninges and the subarachnoid space. It constitutes a true medical emergency requiring immediate diagnostic evaluation and empiric antimicrobial therapy1,3. The disease process is characterised by intense host inflammatory responses triggered by bacterial cell wall components, leading to cerebral oedema, elevated intracranial pressure, compromised cerebral perfusion, and neuronal injury3,4. Despite advances in intensive care management and antimicrobial pharmacotherapy, acute bacterial meningitis remains associated with substantial morbidity and mortality globally4,6.

1. Etiology & Risk Factors

  • Streptococcus pneumoniae (Pneumococcus): The most frequent causative organism in adults across all age groups, particularly associated with pneumonia, otitis media, sinusitis, asplenia, and immunoglobulin deficiencies1,2.
  • Neisseria meningitidis (Meningococcus): Predominantly affects children, adolescents, and young adults, frequently presenting with epidemics, petechial or purpuric cutaneous manifestations, and potential Waterhouse-Friderichsen syndrome1,7.
  • Listeria monocytogenes: Highly prevalent in neonates, individuals older than 50 years, pregnant women, and immunocompromised hosts (cell-mediated immunity defects); requires specific empiric coverage with amoxicillin or aminopenicillins1,2.
  • Haemophilus influenzae type b (Hib): Historically a primary pediatric pathogen; its incidence has dramatically declined following widespread implementation of effective conjugate immunisation programmes6,7.
  • Gram-Negative Bacilli (e.g., Escherichia coli, Klebsiella spp., Pseudomonas aeruginosa): Encountered frequently in neonates, elderly patients, post-neurosurgical settings, and hospital-acquired or traumatic central nervous system infections1,2.
  • Anatomical and Immunological Risk Factors: Basilar skull fractures (especially with cerebrospinal fluid rhinorrhoea or otorrhea), cochlear implants, complement pathway deficiencies (C5-C9), functional or anatomical asplenia, chronic renal failure, and advanced age3,7.

2. Pathophysiology

The pathogenesis of acute bacterial meningitis proceeds through a well-defined sequential cascade. Bacteria initially colonise the mucosal surfaces of the nasopharynx, facilitated by specific adhesins, IgA proteases, and pili. Following mucosal adherence, microorganisms invade the intravascular compartment, evading host complement and phagocytic clearance via polysaccharide capsules. Once bacteraemia is established, bacteria cross the blood-brain barrier, entering the cerebrospinal fluid within the subarachnoid space through mechanisms involving endothelial cell interaction and choroid plexus traversal. Within the subarachnoid space, bacterial replication occurs rapidly due to the relative paucity of local humoral and cellular immune defences. Bacterial lysis and release of toxic cell wall components—such as peptidoglycan fragments, teichoic acid, and pneumolysin—stimulate resident microglia and astrocytes to release potent pro-inflammatory cytokines, including tumour necrosis factor-alpha (TNF-$\alpha$) and interleukin-1 beta (IL-1$\beta$), alongside chemokines and prostaglandins. This intense neuro-inflammatory response drives blood-brain barrier permeability, causing vasogenic oedema, influx of serum proteins, and recruitment of polymorphonuclear leukocytes across the vascular endothelium. Concurrently, cytotoxic and interstitial cerebral oedema develop secondary to cellular metabolic failure and impaired cerebrospinal fluid reabsorption through arachnoid villi. The culmination of these processes is a marked elevation in intracranial pressure, decreased cerebral perfusion pressure, focal cerebral ischaemia, neuronal apoptosis, and potential herniation syndromes if left unchecked3,4,6.

Acute bacterial meningitis — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Bacterial colonisation of nasopharynx and mucosal invasion into the bloodstream 2 Cellular / Pathophysiological Cascade Haematogenous seeding, crossing of the blood-brain barrier, and subarachnoid space proliferation 3 Target Organ / Structural Change Massive local cytokine release, meningeal inflammation, cerebral oedema, and raised intracranial pressure 4 Hallmark Clinical & Diagnostic Manifestation Rapid development of the classic triad, turbid CSF with neutrophilic pleocytosis, and low glucose 5 Complications if Untreated & Therapeutic Target Permanent neurological deficit or death; targeted by immediate antibiotics and anti-inflammatory corticosteroids

3. Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients typically manifest an acute, rapidly progressive clinical syndrome developing over hours to days. The classic triad consists of fever, severe headache, and neck stiffness, though all three features are concurrently present in only a minority of cases. Additional cardinal symptoms include photophobia, nausea, vomiting, profound lethargy, confusion, irritability, and focal or generalised seizures3,7.
  • Physical Examination & Named Clinical Signs: Nuchal rigidity is observed on passive or active neck flexion. Kernig's sign is positive when resistance or pain occurs upon passive extension of the knee with the hip flexed at 90 degrees. Brudzinski's sign is positive when passive flexion of the neck induces involuntary flexion of the hips and knees. Cutaneous examination is critical: the presence of a non-blanching petechial or purpuric rash strongly implicates invasive meningococcal disease. Neurological examination must assess for focal cranial nerve palsies (particularly cranial nerves III, VI, VII, and VIII) and signs of raised intracranial pressure, including papilloedema and Cushing's triad (hypertension, bradycardia, and irregular respirations)3,4.

4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationLumbar puncture demonstrating markedly elevated opening pressure (>20 cm $H_2O$), turbid or purulent cerebrospinal fluid appearance, polymorphonuclear pleocytosis (>1000/mm³, often 1,000–10,000/mm³), elevated cerebrospinal fluid protein (>1 g/L), and a significantly depressed cerebrospinal fluid-to-serum glucose ratio (<0.4, often <0.3 or undetectable). Gram stain and cerebrospinal fluid culture identify the organism in 70–90% of untreated cases. Multiplex PCR assays rapidly detect specific bacterial DNA3,4.
Laboratory PanelComplete blood count reveals significant leukocytosis with a left shift (neutrophilia). Serum inflammatory markers (C-reactive protein and procalcitonin) are markedly elevated. Comprehensive metabolic panel assesses for electrolyte disturbances, particularly syndrome of inappropriate antidiuretic hormone secretion (SIADH) resulting in hyponatraemia, alongside evaluation of renal and hepatic function prior to antimicrobial dosing. Blood cultures must be drawn prior to antibiotic administration and yield positive results in up to 50–80% of patients4,7.
Imaging / Radiology (X-ray, US, CT, MRI)Urgent non-contrast head computed tomography must be performed prior to lumbar puncture only if red-flag criteria are met: new-onset focal neurological deficits, new-onset seizures, severely altered mental status, papilloedema, or immunocompromised state. Imaging rules out space-occupying lesions or impending herniation. Magnetic resonance imaging with contrast is more sensitive for detecting early leptomeningeal enhancement, cerebral venous sinus thrombosis, or microvascular ischaemic infarctions in complicated courses3,4.
ECG / Histopathology / ProceduralElectrocardiogram may demonstrate non-specific ST-segment and T-wave abnormalities secondary to acute systemic stress, catecholamine surge, or myocarditis associated with severe sepsis. Histopathology of post-mortem or biopsy tissue reveals extensive neutrophilic infiltration of the leptomeninges, subarachnoid purulent exudate, congestion of meningeal blood vessels, and microabscess formation3,4.

5. Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
Prognostic Clinical Staging (Bacterial Meningitis Score)Evaluates variables including age, Glasgow Coma Scale score, presence of focal neurological signs, and cerebrospinal fluid laboratory parameters. Higher scores correlate directly with increased risk of mortality, long-term neurological sequelae, and requirement for admission to an intensive care unit. Initial triage guides immediate aggressive supportive care and close monitoring for secondary intracranial complications4,6.
Glasgow Coma Scale (GCS) StratificationGCS 13–15 indicates mild-to-moderate presentation with favourable baseline prognosis. GCS ≤8 indicates severe neurological compromise, stupor, or coma, necessitating immediate endotracheal intubation, mechanical ventilation, invasive intracranial pressure monitoring, and neuro-intensive care admission to manage cerebral perfusion pressure3,4.

6. Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Aseptic (Viral) MeningitisTypically presents with a more benign, self-limiting course. Cerebrospinal fluid analysis reveals lymphocytic pleocytosis, normal glucose levels, and normal or mildly elevated protein. Enteroviruses are the most common etiology; bacterial cultures remain negative, and Gram stain shows no organisms.
Fungal / Tuberculous MeningitisSubacute or chronic presentation evolving over weeks. Cerebrospinal fluid analysis demonstrates lymphocytic or mixed pleocytosis, profoundly low glucose, very high protein, and positive acid-fast bacilli smear, fungal culture, or cryptococcal antigen testing. Patients frequently exhibit cranial neuropathies and basal meningeal enhancement on neuroimaging.
Subarachnoid HaemorrhageSudden onset of thunderclap headache without initial prominent fever. Lumbar puncture demonstrates uniformly blood-stained cerebrospinal fluid across successive collection tubes and presence of xanthochromia upon spectrophotometric centrifugation. Non-contrast computed tomography scan instantly confirms acute subarachnoid hyperattenuation.
Central Nervous System Malignancy (Meningeal Carcinomatosis)Insidious onset of progressive multi-focal neurological signs, cranial nerve palsies, and radicular pain. Cerebrospinal fluid cytology reveals malignant neoplastic cells, elevated protein, and low or normal glucose, occurring predominantly in patients with known systemic malignancies.

7. Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Secure the airway, maintain adequate oxygenation, and establish immediate large-bore intravenous access. Treat systemic hypotension and septic shock aggressively with isotonic crystalloid fluid resuscitation and vasoactive support (e.g., norepinephrine) to maintain adequate mean arterial pressure and cerebral perfusion pressure. Administer prompt antipyretics for fever control and anticonvulsants (e.g., intravenous levetiracetam or lorazepam) if acute seizures occur3,4.
  • First-Line Medical / Pharmacological Therapy (with exact adult dosing):
    • Initiate empiric antimicrobial therapy immediately upon suspicion of acute bacterial meningitis, ideally within 30 to 60 minutes of presentation. Do not delay antibiotic administration for lumbar puncture if imaging or logistical delays occur.
    • Standard Empiric Regimen: Intravenous Ceftriaxone 2 grams administered every 12 hours (BD) to cover Streptococcus pneumoniae and Neisseria meningitidis.
    • Expanded Empiric Regimen: For patients aged over 50 years, immunocompromised states, or pregnancy (to ensure adequate coverage for Listeria monocytogenes), add Intravenous Amoxicillin 2 grams administered every 4 hours (q4h). Alternatively, substitute with IV Meropenem if Pseudomonas aeruginosa risk is present2,7.
    • Adjunctive Corticosteroid Therapy: Intravenous Dexamethasone 10 milligrams administered every 6 hours (q6h) for 4 days. The first dose must be administered either prior to or concurrently with the first dose of antimicrobial therapy to attenuate subarachnoid space inflammation and reduce the incidence of sensorineural hearing loss and neurological sequelae, particularly in pneumococcal meningitis2,5.
  • Surgical / Interventional Indications: Urgent neurosurgical intervention is indicated for the placement of an external ventricular drain or intracranial pressure monitor in patients with severe progressive hydrocephalus or intractable intracranial hypertension. Surgical drainage may also be required for associated subdural empyemas, epidural abscesses, or focal intracranial abscess collections refractory to medical management alone3,4.

8. Complications & Prognosis

  • Acute Complications: Raised intracranial pressure, cerebral oedema, cerebral herniation syndromes, communicating or obstructive hydrocephalus, seizures, focal cerebral infarction resulting from septic cerebral arteritis or venous sinus thrombosis, cranial nerve palsies (most frequently affecting cranial nerves VI and VIII, leading to visual gaze abnormalities and sensorineural hearing loss), syndrome of inappropriate antidiuretic hormone secretion, and systemic complications such as disseminated intravascular coagulation and septic shock3,4,6.
  • Long-Term Neurological Sequelae: Persistent cognitive impairment, memory deficits, behavioural disturbances, permanent sensorineural hearing loss, motor deficits, epilepsy, and balance disorders4,5.
  • Mortality and Prognosis: Overall mortality rates in adults range from 20% to 30% depending on the specific causative pathogen (highest in pneumococcal disease), patient age, and timeliness of antimicrobial therapy initiation. Advanced age, low baseline Glasgow Coma Scale score at presentation, and delayed initiation of effective antimicrobial treatment are the strongest predictors of poor clinical outcome and mortality3,4,6.